We recently published a list of 13 Best Defense Stocks to Buy According to Billionaires. In this article, we are going to ...

We recently published a list of 13 Best Defense Stocks to Buy According to Billionaires. In this article, we are going to ...

As if things weren’t jittery enough, a plunge in the S&P 500’s most influential group — big tech — weighed heavily on trading ...

Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...

For two consecutive years, stock-market prognosticators lifted their outlooks for the S&P 500 Index over and over again to ...

We recently published a list of 13 Best Defense Stocks to Buy According to Billionaires. In this article, we are going to ...

We recently published a list of 13 Best Defense Stocks to Buy According to Billionaires. In this article, we are going to ...

Anxiety that tariffs and government firings will torpedo growth in the world’s largest economy extended a three-week stretch ...

Market forecasters at banks including JPMorgan Chase & Co. and RBC Capital Markets have also tempered bullish calls for 2025 as Trump’s tariffs stoke fears of slowing economic growth. The S&P 500 has ...

For the week, the S&P 500 logged a 3.1% decline, marking its worst performance since September. The Dow shed 2.4% over the ...

Wall Street is on edge again, but the culprit this time isn’t just inflation. Instead, equities investors large and small are gripped by fear of slowing economic growth in the US. The S&P 500 Index ...

RBC Capital keeps a Buy rating and $82 price target on Cytokinetics (CYTK), saying the firm remains bullish on the stock following the ...